Document:

EX-10.1

Exhibit 10.1

DUSA PHARMACEUTICALS, INC.

2006 EQUITY COMPENSATION PLAN

As amended July 31, 2008

     The purpose of the DUSA Pharmaceuticals, Inc. 2006 Equity Compensation Plan (the “Plan”) is to
provide (i) designated employees of DUSA Pharmaceuticals, Inc. (the “Company”) and its parents and
subsidiaries, (ii) certain consultants and advisors who perform services for the Company or its
parents or subsidiaries, and (iii) non-employee members of the Board of Directors of the Company
(the “Board”) with the opportunity to receive grants of incentive stock options, nonqualified stock
options, stock awards, and stock appreciation rights. The Company believes that the Plan will
encourage the participants to contribute materially to the growth of the Company, thereby
benefiting the Company’s shareholders, and will align the economic interests of the participants
with those of the shareholders.

     1. Administration

     (a) Committee. The Plan shall be administered and interpreted by the members of the
Compensation Committee of the Board (the “Committee”), which consists of “outside directors” as
defined under Section 162(m) of the Internal Revenue Code of 1986, as amended (the “Code”), and
related Treasury regulations, and “non-employee directors” as defined under Rule 16b-3 under the
Securities Exchange Act of 1934, as amended (the “Exchange Act”). However, the Board may ratify or
approve any grants as it deems appropriate, and an independent committee of the Board shall approve
and administer all grants made to non-employee directors. The Committee may delegate authority to
one (1) or more delegates as it deems appropriate.

     (b) Committee Authority. The Committee or its delegate shall have the sole authority
to (i) determine the individuals to whom grants shall be made under the Plan; (ii) determine the
type, size, and terms of the grants to be made to each such individual; (iii) determine the time
when the grants will be made and the duration of any applicable exercise or restriction period,
including the criteria for exercisability and the acceleration of exercisability; (iv) amend the
terms of any previously issued grant; and (v) deal with any other matters arising under the Plan.
Notwithstanding anything in this Plan to the contrary, in no event may the Board, the Committee or
its or their delegate (i) amend or modify an Option in a manner that would reduce the exercise
price of such Option; (ii) substitute an Option for another Option with a lower exercise price;
(iii) cancel an Option and issue a new Option with a lower exercise price to the holder of the
cancelled Option within six (6) months following the date of the cancellation of the cancelled
Option; (iv) cancel an outstanding Option that is under water (i.e., for which the Fair Market
Value, as defined below, of the underlying Shares are less than the Option’s Exercise Price, as
defined below) for the purpose of granting a replacement Grant (as defined below) of a different
type; (v) grant a full value performance award pursuant to Section 6 that vests in less than one
year from the date of grant; (vi) grant a full value award that is not subject to performance
vesting that vests in less than three years; or (vii) waive the minimum vesting periods described
in Sections 1(b)(v) or (vi) above.

 

 

     (c) Committee Determinations. The Committee shall have full power and authority to
administer and interpret the Plan, to make factual determinations and to adopt or amend such rules,
regulations, agreements, and instruments for implementing the Plan and for the conduct of its
business as it deems necessary or advisable, in its sole discretion. The Committee’s
interpretations of the Plan and all determinations made by the Committee pursuant to the powers
vested in it hereunder shall be conclusive and binding on all persons having any interest in the
Plan or in any awards granted hereunder. All powers of the Committee shall be executed in its sole
discretion, in the best interest of the Company, not as a fiduciary, and in keeping with the
objectives of the Plan and need not be uniform as to similarly situated individuals.

     (d) Other Equity Awards. The terms of this Plan shall not impact or govern the
administration by the Company or the rights of any holders of an option or stock award granted
pursuant to the DUSA Pharmaceuticals, Inc., 1996 Omnibus Plan, as amended (the “Prior Plan”).
Unless otherwise provided by the Company and agreed to by the recipient of an award under the Prior
Plan, all awards granted pursuant to the Prior Plan shall continue to be governed by the terms of
such plan.

     2. Grants

     (a) Awards under the Plan may consist of grants of incentive stock options as described in
Section 5 (“Incentive Stock Options”), nonqualified stock options as described in Section 5
(“Nonqualified Stock Options”) (Incentive Stock Options and Nonqualified Stock Options are
collectively referred to as “Options”), stock awards as described in Section 6 (“Stock Awards”) and
Stock Appreciation Rights described in Section 7 (“SARs”) (hereinafter collectively referred to as
“Grants”). All Grants shall be subject to the terms and conditions set forth herein and to such
other terms and conditions consistent with this Plan and as specified in the individual grant
instrument or an amendment to the grant instrument (the “Grant Instrument”). All Grants shall be
made conditional upon the Grantee’s acknowledgement, in writing or by acceptance of the Grant, that
all decisions and determinations of the Company shall be final and binding on the Grantee, his or
her beneficiaries and any other person having or claiming an interest under such Grant. Grants
under a particular Section of the Plan need not be uniform as among the grantees.

     3. Shares Subject to the Plan

     (a) Shares Authorized. Subject to adjustment as described below, (i) the maximum
aggregate number of shares of common stock of the Company (“Company Stock”) that may be issued or
transferred under any forms of grants under the Plan is the lesser of (i) 20% of the total number
of shares of common stock of the Company issued and outstanding at any given time less the number
of shares issued and outstanding under any other equity compensation plan of the Company at such
time; or (ii) 4,815,690 shares less the number of shares issued and outstanding under any other
equity compensation plan of the Company from time to time, all of which may be issued as Incentive
Stock Options. The maximum aggregate number of shares of Company Stock that shall be subject to
Grants made under the Plan to any individual during any calendar year shall be

-2-

 

300,000 shares, subject to adjustment as described below. The shares may be authorized but
unissued shares of Company Stock or reacquired shares of Company Stock, including shares purchased
by the Company on the open market for purposes of the Plan. If and to the extent Options granted
under the Plan terminate, expire, or are canceled, forfeited, exchanged, or surrendered without
having been exercised or if any Stock Awards (including restricted Stock Awards received upon the
exercise of Options) are forfeited, the shares subject to such Grants shall again be available for
purposes of the Plan.

     (b) Adjustments. If there is any change in the number or kind of shares of Company
Stock outstanding (i) by reason of a stock dividend, spinoff, recapitalization, stock split, or
combination or exchange of shares; (ii) by reason of a merger, reorganization, or consolidation;
(iii) by reason of a reclassification or change in par value; or (iv) by reason of any other
extraordinary or unusual event affecting the outstanding Company Stock as a class without the
Company’s receipt of consideration, or if the value of outstanding shares of Company Stock is
substantially reduced as a result of a spinoff or the Company’s payment of an extraordinary
dividend or distribution, the maximum number of shares of Company Stock available for Grants, the
maximum number of shares of Company Stock that any individual participating in the Plan may be
granted in any year, the number of shares covered by outstanding Grants, the kind of shares issued
under the Plan, and the price per share of such Grants may be appropriately adjusted by the Company
to reflect any increase or decrease in the number of, or change in the kind or value of, issued
shares of Company Stock to preclude, to the extent practicable, the enlargement or dilution of
rights and benefits under such Grants; provided, however, that any fractional shares resulting from
such adjustment shall be rounded down to the nearest whole share. Any adjustments determined by
the Company shall be final, binding, and conclusive.

     4. Eligibility for Participation

     (a) Eligible Persons. All employees of the Company and its parents or subsidiaries
(“Employees”), including Employees who are officers or members of the Board, and members of the
Board who are not Employees (“Non-Employee Directors”) shall be eligible to participate in the
Plan. Consultants and advisors who perform services for the Company or any of its parents or
subsidiaries (“Key Advisors”) shall be eligible to participate in the Plan if the Key Advisors
render bona fide services to the Company or its parents or subsidiaries, the services are not in
connection with the offer and sale of securities in a capital-raising transaction, and the Key
Advisors do not directly or indirectly promote or maintain a market for the Company’s securities.

     (b) Selection of Grantees. The Company shall select the Employees, Non-Employee
Directors, and Key Advisors to receive Grants and shall determine the number of shares of Company
Stock subject to a particular Grant. Employees, Key Advisors, and Non-Employee Directors who
receive Grants under this Plan shall hereinafter be referred to as “Grantees.”

-3-

 

     5. Granting of Options

     The Company may grant an Option to an Employee, Non-Employee Director, or Key Advisor. The
following provisions are applicable to Options.

     (a) Number of Shares. The Company shall determine the number of shares of Company
Stock that will be subject to each Grant of Options to Employees, Non-Employee Directors, and Key
Advisors.

     (b) Type of Option and Price.

          (i) Incentive Stock Options are intended to satisfy the requirements of Section 422 of the
Code. Nonqualified Stock Options are not intended to so qualify. Incentive Stock Options may be
granted only to employees of the Company or its parents or subsidiaries, as defined in Section 424
of the Code. Nonqualified Stock Options may be granted to Employees, Non-Employee Directors, and
Key Advisors.

          (ii) The purchase price (the “Exercise Price”) of Company Stock subject to an Option may be
equal to or greater than the Fair Market Value (as defined below) of a share of Company Stock on
the date the Option is granted; provided, however, that (x) the Exercise Price of an Incentive
Stock Option shall be equal to, or greater than, the Fair Market Value of a share of Company Stock
on the date the Incentive Stock Option is granted and (y) an Incentive Stock Option may not be
granted to an Employee who, at the time of grant, owns or beneficially owns stock possessing more
than ten percent (10%) of the total combined voting power of all classes of stock of the Company or
any parent or subsidiary of the Company, unless the Exercise Price per share is not less than one
hundred ten percent (110%) of the Fair Market Value of Company Stock on the date of grant.

          (iii) So long as the Company Stock is publicly traded, the Fair Market Value per share shall
be determined as follows: (x) if the principal trading market for the Company Stock is a national
securities exchange or the Nasdaq National Market, the last reported sale price thereof on the
relevant date or (if there were no trades on that date) the latest preceding date upon which a sale
was reported, or (y) if the Company Stock is not principally traded on such exchange or market, the
mean between the last reported “bid” and “asked” prices of Company Stock on the relevant date, as
reported on Nasdaq or, if not so reported, as reported by the National Daily Quotation Bureau, Inc.
or as reported in a customary financial reporting service, as applicable and as the Company
determines. If the Company Stock is not publicly traded or, if publicly traded, is not subject to
reported transactions or “bid” or “asked” quotations as set forth above, the Fair Market Value per
share shall be as determined by the Company.

     (c) Option Term. The term of any Option shall not exceed seven (7) years from the
date of grant. However, an Incentive Stock Option that is granted to an Employee who, at the time
of grant, owns or beneficially owns stock possessing more than ten percent (10%) of the total
combined voting power of all classes of stock of the Company, or any parent or subsidiary of the
Company, may not have a term that exceeds five (5) years from the date of grant.

-4-

 

     (d) Exercisability of Options.

          (i) Options shall become exercisable in accordance with such terms and conditions of the Plan
and specified in the Grant Instrument. The Company may not accelerate the exercisability of any
outstanding Options except in the case of death, disability, retirement or change in control.
Notwithstanding the preceding sentence, the Company may accelerate the exercisability of any
outstanding Options for reasons other than death, disability, retirement or change in control,
provided that the aggregate number of shares of Company Stock underlying Options that may be
accelerated for reasons other than death, disability, retirement or change in control together with the
aggregate number of Stock Awards that contain vesting restrictions that may be waived by the
Company for reasons other than death, disability, retirement or change in control, will not exceed
ten (10%) percent of the shares authorized for issuance under the Plan.

          (ii) The Company may provide in a Grant Instrument that the Grantee may elect to exercise part
or all of an Option before it otherwise has become exercisable. Any shares so purchased shall be
restricted shares and shall be subject to a repurchase right in favor of the Company during a
specified restriction period, with the repurchase price equal to the lesser of (i) the Exercise
Price or (ii) the Fair Market Value of such shares at the time of repurchase, and (iii) any other
restrictions determined by the Company.

     (e) Grants to Non-Exempt Employees. Options granted to persons who are non-exempt
employees under the Fair Labor Standards Act of 1938, as amended, shall have an Exercise Price not
less than one hundred percent (100%) of the Fair Market Value of the Company Stock on the date of
grant, and may not be exercisable for at least six (6) months after the date of grant (except that
such Options may become exercisable upon the Grantee’s death, Disability or retirement, or upon a
Change in Control or other circumstances permitted by applicable regulations).

     (f) Termination of Employment, Disability, or Death.

          (i) Except as provided below, an Option may only be exercised while the Grantee is employed
by, or providing service to, the Employer (as defined below) as an Employee, Key Advisor or member
of the Board. In the event that a Grantee ceases to be employed by, or provide service to, the
Employer for any reason other than Disability, death, termination for Misconduct, or as set forth
in subsection 5(f)(v) of this Plan, any Option which is otherwise exercisable by the Grantee shall
terminate unless exercised within ninety (90) days after the date on which the Grantee ceases to be
employed by, or provide service to, the Employer (or within such other period of time as may be
specified by the Company), but in any event no later than the date of expiration of the Option
term. Except as otherwise provided, any of the Grantee’s Options that are not otherwise
exercisable as of the date on which the Grantee ceases to be employed by, or provide service to,
the Employer shall terminate as of such date.

          (ii) In the event the Grantee ceases to be employed by, or provide service to, the Employer on
account of a termination by the Employer for Misconduct,

-5-

 

any Option held by the Grantee shall terminate at the time that the Grantee ceases to be
employed by, or provide service to, the Employer or the date on which such Option would otherwise
expire, if earlier. In addition, notwithstanding any other provisions of this Section 5, if the
Company determines that the Grantee has engaged in conduct that constitutes Misconduct at any time
while the Grantee is employed by, or providing service to, the Employer or after the Grantee’s
termination of employment or service, any Option held by the Grantee shall terminate as of the
thirtieth (30th) day after the date on which such Misconduct first occurred, or the date
on which such Option would otherwise expire, if earlier. Upon any exercise of an Option, the
Company may withhold delivery of share certificates pending resolution of an inquiry that could
lead to a finding resulting in a forfeiture.

          (iii) In the event the Grantee ceases to be employed by, or provide service to, the Employer
because the Grantee is Disabled, any Option which is otherwise exercisable by the Grantee shall
terminate unless exercised within one (1) year after the date on which the Grantee ceases to be
employed by, or provide service to, the Employer (or within such other period of time as may be
specified by the Company), but in any event no later than the date of expiration of the Option
term. Except as otherwise provided, any of the Grantee’s Options that are not otherwise
exercisable as of the date on which the Grantee ceases to be employed by, or provide service to,
the Employer shall terminate as of such date.

          (iv) If the Grantee dies while employed by, or providing service to, the Employer, all of the
unexercised outstanding Options of Grantee shall become immediately exercisable and remain
exercisable for a period of one (1) year from his or her date of death, but in no event later than
the date of expiration of the Option term. If the Grantee dies within ninety (90) days after the
date on which the Grantee ceases to be employed or provide service on account of a termination
specified in Section 5(f)(i) above (or within such other period of time as may be specified by the
Company), any Option that is otherwise exercisable by the Grantee shall terminate unless exercised
within one (1) year after the date on which the Grantee ceases to be employed by, or provide
service to, the Employer (or within such other period of time as may be specified), but in any
event no later than the date of expiration of the Option term. Except as otherwise provided, any
of the Grantee’s Options that are not otherwise exercisable as of the date on which the Grantee
ceases to be employed by, or provide service to, the Employer shall terminate as of such date.

          (v) Notwithstanding anything herein to the contrary, to the extent that any Company-sponsored
plan or arrangement, or any agreement to which the Company is a party expressly provides for a
longer exercise period for a Grantee’s Options under applicable circumstances than the exercise
period that is provided for in this Section 5(f) under those circumstances, then the exercise
period set forth in such plan, arrangement or agreement applicable to such circumstances shall
apply in lieu of the exercise period provided for in this Section 5(f).

          (vi) For purposes of this Section 5(f) and Section 6:

-6-

 

     (A) The term “Employer” shall mean the Company and its parent and subsidiary
corporations or other entities, as determined by the Board.

     (B) “Employed by, or provide service to, the Employer” shall mean employment or
service as an Employee, Key Advisor or member of the Board (so that, for purposes of
exercising Options or SARs and satisfying conditions with respect to Stock Awards, a
Grantee shall not be considered to have terminated employment or service until the Grantee
ceases to be an Employee, Key Advisor or member of the Board).

     (C) “Disability” shall mean a Grantee’s becoming disabled within the meaning of the
Employer’s long-term disability plan applicable to the Grantee, as determined in the sole
discretion of the Committee or its delegate.

     (D) “Misconduct” means (i) any activity that constitutes a material violation of a
provision of the Company’s handbook or a breach of any conduct clause in an employment
agreement between the Company and Grantee; (ii) indictment for, or conviction of, a crime
that constitutes a felony or for which imprisonment for more than one year is a possible
penalty; or (iii) habitual or regular intoxication.

     (g) Exercise of Options. A Grantee may exercise an Option that has become
exercisable, in whole or in part, by delivering a notice of exercise to the Company. The Grantee
shall pay the Exercise Price for an Option as specified by the Company (i) in cash, (ii) payment
through a broker in accordance with procedures permitted by Regulation T of the Federal Reserve
Board, or (iii) by such other method as the Company may approve. Shares of Company Stock used to
exercise an Option shall have been held by the Grantee for the requisite period of time to avoid
adverse accounting consequences to the Company with respect to the Option. The Grantee shall pay
the Exercise Price and the amount of any withholding tax due (pursuant to Section 8).

     (h) Limits on Incentive Stock Options. Each Incentive Stock Option shall provide
that, if the aggregate Fair Market Value of the Company Stock on the date of the grant with respect
to which Incentive Stock Options are exercisable for the first time by a Grantee during any
calendar year, under the Plan or any other stock option plan of the Company or a parent or
subsidiary, exceeds One Hundred Thousand Dollars ($100,000), then the Option, as to the excess,
shall be treated as a Nonqualified Stock Option. An Incentive Stock Option shall not be granted to
any person who is not an Employee of the Company or a parent or subsidiary (within the meaning of
Section 424(f) of the Code) of the Company.

     (i) Formula Grants. Non-Employee Directors shall be eligible to receive a
nonqualified stock option under the Plan. Each individual who agrees to become a Non-Employee
Director shall receive, on June 30th of the first year of such service or as of the
close of business thirty (30) days following his/her election, whichever shall first occur, and
without the exercise of the discretion of any person, an Option relating to the purchase of 15,000
shares of Company Stock at an exercise price equal to the Fair Market

-7-

 

Value on the date the Option is granted. Thereafter, on June 30th of each year,
each individual who is a continuing Non-Employee Director shall receive, without the exercise of
the discretion of any person, an Option under the Plan relating to the purchase of 10,000 shares of
Company Stock. Each Option granted under this paragraph shall vest in full on the date of the
grant and have a term not to exceed seven (7) years from the date of grant, or, if later, the date
the Grantee becomes a Non-Employee Director. Notwithstanding the exercise period of any such
Option, all such Options shall immediately become exercisable upon (i) the death of Non-Employee
Director while serving as such, or (ii) upon a Change of Control.

     6. Stock Awards

     The Company may transfer shares of Company Stock or cash to an Employee, Non-Employee
Director, or Key Advisor under a Stock Award. The following provisions are applicable to Stock
Awards:

     (a) General Requirements. Shares of Company Stock issued or transferred pursuant to
Stock Awards may be issued or transferred for consideration or for no consideration, and subject to
a minimum of a one (1) year vesting period for performance awards and a minimum three (3) year
vesting period for awards not subject to performance vesting. The Committee shall not be permitted
to waive such vesting periods except in the case of death, disability, retirement, or change in
control. Notwithstanding the preceding sentence, the Committee may waive the vesting restrictions
of any shares of Company Stock for reasons other than death, disability, retirement or change in
control, provided that the aggregate number of shares of Company Stock that contain vesting
restrictions that may be waived by the Committee for reasons other than death, disability,
retirement or change in control together with the aggregate number of shares of Company Stock
underlying Options that may be accelerated by the Committee for reasons other than death,
disability, retirement or change in control, will not exceed ten (10%) percent of the shares of
Company Stock authorized for issuance under the Plan. Restrictions on Stock Awards shall lapse
over a period of time or according to such other criteria as set forth in the Grant Instrument.
The period of time during which the Stock Award will remain subject to restrictions will be
designated in the Grant Instrument as the “Restriction Period.”

     (b) Number of Shares. The Grant Instrument shall set forth the number of shares of
Company Stock to be issued or transferred pursuant to a Stock Award and the restrictions applicable
to such shares.

     (c) Requirement of Employment or Service. If the Grantee ceases to be employed by, or
provide service to, the Employer (as defined in Section 5(f)) during a period designated in the
Grant Instrument as the Restriction Period, or if other specified conditions are not met, the Stock
Award shall terminate as to all shares covered by the award as to which the restrictions have not
lapsed, and those shares of Company Stock must be immediately returned to the Company. The Company
may, however, provide for complete or partial exceptions to this requirement as it deems
appropriate.

-8-

 

     (d) Restrictions on Transfer and Legend on Stock Certificate. During the Restriction
Period, a Grantee may not sell, assign, transfer, pledge, or otherwise dispose of the shares of the
Stock Award except to a successor under Section 9(a). Each certificate for Stock Awards shall
contain a legend giving appropriate notice of the restrictions in the Grant. The Grantee shall be
entitled to have the legend removed from the stock certificate covering the shares subject to
restrictions when all restrictions on such shares have lapsed. The Company may determine that it
will not issue certificates for Stock Awards until all restrictions on such shares have lapsed, or
that the Company will retain possession of certificates for Stock Awards until all restrictions on
such shares have lapsed.

     (e) Right to Vote and to Receive Dividends. During the Restriction Period, the
Grantee shall not have the right to vote shares subject to Stock Awards or to receive any dividends
or other distributions paid on such shares.

     (f) Lapse of Restrictions. All restrictions imposed on Stock Awards shall lapse upon
the expiration of the applicable Restriction Period and the satisfaction of all conditions. The
Company may determine, as to any or all Stock Awards, that the restrictions shall lapse without
regard to any Restriction Period.

     (g) Designation as Qualified Performance-Based Compensation. The Committee may
determine that Stock Awards granted to an Employee shall be considered “qualified performance-based
compensation” under Section 162(m) of the Code. The provisions of this paragraph (g) shall apply
to Stock Awards that are to be considered “qualified performance-based compensation” under Section
162(m) of the Code.

          (i) Performance Goals. When Stock Awards that are to be considered “qualified
performance-based compensation” are granted, the Committee shall establish in writing (A) the
objective performance goals that must be met, (B) the performance period during which the
performance goals must be met (the “Performance Period”), (C) the threshold, target and maximum
amounts that may be paid if the performance goals are met, and (D) any other conditions that the
Committee deems appropriate and consistent with the Plan and Section 162(m) of the Code. The
performance goals may relate to the Employee’s business unit or the performance of the Company and
its parents and subsidiaries as a whole, or any combination of the foregoing. The Committee shall
use objectively determinable performance goals based on one or more of the following criteria:
stock price, earnings per share, net earnings, operating earnings, return on assets, shareholder
return, return on equity, growth in assets, unit volume, sales, market share, or strategic business
criteria consisting of one or more objectives based on meeting specified revenue goals, market
penetration goals, geographic business expansion goals, cost targets or goals relating to
acquisitions or divestitures.

          (ii) Establishment of Goals. The Committee shall establish the performance goals in
writing either before the beginning of the Performance Period or during a period ending no later
than the earlier of (i) ninety (90) days after the beginning of the Performance Period or (ii) the
date on which twenty-five percent (25%) of the Performance Period has been completed, or such other
date as may be required or

-9-

 

permitted under applicable regulations under Section 162(m) of the Code. The performance
goals shall satisfy the requirements for “qualified performance-based compensation,” including the
requirement that the achievement of the goals be substantially uncertain at the time they are
established and that the goals be established in such a way that a third party with knowledge of
the relevant facts could determine whether and to what extent the performance goals have been met.
The Committee shall not have discretion to increase the amount of compensation that is payable upon
achievement of the designated performance goals.

          (iii) Maximum Payment. If Stock Awards, measured with respect to the Fair Market
Value of Company Stock, are granted, not more than one hundred thousand (100,000) shares of Company
Stock may be granted to an Employee under the Stock Award for any Performance Period.

          (iv) Announcement of Grants. The Committee shall certify and announce the results for
each Performance Period to all Grantees immediately following the announcement of the Company’s
financial results for the Performance Period. If and to the extent that the Committee does not
certify that the performance goals have been met, the grants of Stock Awards for the Performance
Period shall be forfeited or shall not be made, as applicable.

          (v) Death, Disability or Other Circumstances. The Committee may provide that Stock
Awards shall be payable or restrictions on Stock Awards shall lapse, in whole or in part, in the
event of the Grantee’s death or Disability during the Performance Period, or under other
circumstances consistent with the Treasury regulations and rulings under Section 162(m) of the
Code.

     (h) Restricted Stock Units. The Committee or its delegate may grant restricted stock
units (“Restricted Units”) to an Employee or Key Advisor. Each Restricted Unit shall represent the
right of the Grantee to receive an amount in cash or Common Stock (as determined by the Committee
or its delegate) based on the value of the Restricted Unit, if performance goals established by the
Committee are met or upon the lapse of a specified vesting period. A Restricted Unit shall be
based on the Fair Market Value of a share of Company Stock or on such other measurement base as the
Committee or its delegate deems appropriate. The Committee or its delegate shall determine the
number of Restricted Units to be granted and the requirements applicable to such Restricted Units.

     7. Stock Appreciation Rights

     The Company may grant SARs to an Employee, Non-Employee Director, or Key Advisor. The
following provisions are applicable to SARs.

     (a) General Requirements. The Company may grant SARs to an Employee, Non-Employee
Director or Key Advisor separately or in tandem with any Option (for all or a portion of the
applicable Option). Tandem SARs may be granted either at the time the Option is granted or at any
time thereafter while the Option remains outstanding;

-10-

 

provided, however, that, in the case of an Incentive Stock Option, SARs may be granted only at
the time of the grant of the Incentive Stock Option. Unless otherwise specified in the Grant
Instrument, the base amount of each SAR shall be equal to the per share Exercise Price of the
related Option or, if there is no related Option, the Fair Market Value of a share of Company Stock
as of the date of grant of the SAR.

     (b) Tandem SARs. In the case of tandem SARs, the number of SARs granted to a Grantee
that shall be exercisable during a specified period shall not exceed the number of shares of
Company Stock that the Grantee may purchase upon the exercise of the related Option during such
period. Upon the exercise of an Option, the SARs relating to the Company Stock covered by such
Option shall terminate. Upon the exercise of SARs, the related Option shall terminate to the
extent of an equal number of shares of Company Stock.

     (c) Exercisability. A SAR shall be exercisable during the period specified in the
Grant Instrument and shall be subject to such vesting and other restrictions as may be specified.
The Company may accelerate the exercisability of any or all outstanding SARs at any time for any
reason. SARs may only be exercised while the Grantee is employed by, or providing service to, the
Employer or during the applicable period after termination of employment or service as described in
Section 5(f). A tandem SAR shall be exercisable only during the period when the Option to which it
is related is also exercisable.

     (d) Grants to Non-Exempt Employees. Notwithstanding the foregoing, SARs granted to
persons who are non-exempt employees under the Fair Labor Standards Act of 1938, as amended, shall
have a base amount not less than one hundred percent (100%) of the Fair Market Value of the Company
Stock on the date of grant, and may not be exercisable for at least six (6) months after the date
of grant (except that such SARs may become exercisable, as determined by the Committee, upon the
Grantee’s death, Disability or retirement, or upon a Change of Control or other circumstances
permitted by applicable regulations).

     (e) Value of SARs. When a Grantee exercises SARs, the Grantee shall receive in
settlement of such SARs an amount equal to the value of the stock appreciation for the number of
SARs exercised, payable in Company Stock. The stock appreciation for a SAR is the amount by which
the Fair Market Value of the underlying Company Stock on the date of exercise of the SAR exceeds
the base amount of the SAR as described in subsection (a). For purposes of calculating the number
of shares of Company Stock to be received, shares of Company Stock shall be valued at their Fair
Market Value on the date of exercise of the SAR. Notwithstanding anything to the contrary, the
Company may pay the appreciation of a SAR in the form of cash, shares of Company Stock, or a
combination of the two, so long as the ability to pay such amount in cash does not result in the
Grantee incurring taxable income related to the SAR prior to the Grantee’s exercise of the SAR.

     (f) Number of SARs Authorized for Issuance. For purposes of 3(a) of the Plan, stock
appreciation rights to be settled in shares of Company Stock shall be counted

-11-

 

in full against the number of shares available for award under the Plan, regardless of the
number of exercise gain shares issued upon the settlement of the stock appreciation right.

     8. Withholding of Taxes

     (a) Required Withholding. All Grants under the Plan shall be subject to applicable
federal (including FICA), state, and local tax withholding requirements. The Employer may require
that the Grantee or other person receiving or exercising Grants pay to the Employer the amount of
any federal, state, or local taxes that the Employer is required to withhold with respect to such
Grants, or the Employer may deduct from other wages paid by the Employer the amount of any
withholding taxes due with respect to such Grants.

     (b) Election to Withhold Shares. If the Company so permits, a Grantee may elect to
satisfy the Employer’s income tax withholding obligation with respect to a Grant by having shares
withheld up to an amount that does not exceed the Grantee’s minimum applicable withholding tax rate
for federal (including FICA), state, and local tax liabilities. The election must be in a form and
manner prescribed by the Company.

     9. Transferability of Grants

     (a) Nontransferability of Grants. Except as provided below, only the Grantee may
exercise rights under a Grant during the Grantee’s lifetime. A Grantee may not transfer those
rights except (i) by will or by the laws of descent and distribution or (ii) with respect to SARs
and Option grants other than Incentive Stock Options, pursuant to a domestic relations order or
otherwise as permitted by the Company. When a Grantee dies, the personal representative or other
person entitled to succeed to the rights of the Grantee may exercise such rights. Any such
successor must furnish proof satisfactory to the Company of his or her right to receive the Grant
under the Grantee’s will or under the applicable laws of descent and distribution.

     (b) Transfer of Nonqualified Stock Options. Notwithstanding the foregoing, the Grant
Instrument may provide that a Grantee may transfer Nonqualified Stock Options to family members, or
one or more trusts or other entities for the benefit of or owned by family members, consistent with
applicable securities laws, provided that the Grantee receives no consideration for the transfer of
an Option and the transferred Option shall continue to be subject to the same terms and conditions
as were applicable to the Option immediately before the transfer.

     10. Change in Control of the Company

     (a) “Change in Control” means the consummation of a transaction that is the subject of a
determination (which may be made effective as of a particular date specified by the Board) by the
Board, made by a majority vote that a change in control has occurred, or is about to occur. Such a
change shall not include, however, a restructuring, reorganization, merger or other change in
capitalization in which the Persons who own an interest in the Company on the date hereof (the
“Current Owners”) (or any individual or entity which receives from a Current Owner an interest in
the Company through will or

-12-

 

the laws of descent and distribution) maintain more than a fifty percent (50%) interest in the
resultant entity. Regardless of the vote of the Board or whether or not the Board votes, a Change
in Control will be deemed to have occurred as of the first day any one (1) or more of the following
subsections shall have been satisfied:

     (b) Any Person (other than the Person in control of the Company as of the date of this Plan,
or other than a trustee or other fiduciary holding securities under an employee benefit plan of the
Company, or a company owned directly or indirectly by the shareholders of the Company in
substantially the same proportions as their ownership of stock of the Company), becomes the
beneficial owner, directly or indirectly, of securities of the Company representing more than
thirty-five percent (35%) of the combined voting power of the Company’s then outstanding
securities; or

     (c) The shareholders of the Company approve:

          (i) A plan of complete liquidation of the Company;

          (ii) An agreement for the sale or disposition of all or substantially all of the Company’s
assets; or

          (iii) A merger, consolidation or reorganization of the Company with or involving any other
company, other than a merger, consolidation or reorganization that would result in the voting
securities of the Company outstanding immediately prior thereto continuing to represent (either by
remaining outstanding or by being converted into voting securities of the surviving entity) at
least fifty percent (50%) of the combined voting power of the voting securities of the Company (or
such surviving entity) outstanding immediately after such merger, consolidation or reorganization.

     (d) However, in no event shall a Change in Control be deemed to have occurred, with respect to
a Grantee, if the Employee is part of a purchasing group which consummates the Change in Control
transaction. A Grantee shall be deemed “part of the purchasing group” for purposes of the
preceding sentence if the Grantee is an equity participant or has agreed to become an equity
participant in the purchasing company or group (except for (i) passive ownership of less than five
percent (5%) of the voting securities of the purchasing company; or (ii) ownership of equity
participation in the purchasing company or group which is otherwise deemed not to be significant,
as determined prior to the Change in Control by a majority of the non-employee continuing Directors
of the Board).

     11. Consequences of a Change in Control

     (a) Notice and Acceleration. Upon a Change in Control, unless the Company determines
otherwise, (i) the Company shall provide each Grantee with outstanding Grants written notice of
such Change in Control, (ii) all outstanding Options and SARs shall automatically accelerate and
become fully exercisable, and (iii) the restrictions and conditions on all outstanding Stock Awards
shall immediately lapse.

-13-

 

     (b) Assumption of Grants. Upon a Change in Control where the Company is not the
surviving corporation (or survives only as a subsidiary of another corporation), unless the Board
determines otherwise, all outstanding Options and SARs that are not exercised shall be assumed by,
or replaced with comparable options or stock appreciation rights by, the surviving corporation (or
a parent or subsidiary of the surviving corporation), and outstanding Stock Awards shall be
converted to Stock Awards of the surviving corporation (or a parent or subsidiary of the surviving
corporation). However, the Board may require each Grantee to surrender his or her outstanding
Options, SARs, or Stock Awards in exchange for a payment by the Company, in cash or Company Stock
(as the Board may determine) in an amount equal to the amount by which the then Fair Market Value
of the shares of Company Stock underlying the Option or SAR exceeds the Exercise Price of the
Grantee’s unexercised Options or the base amount of the Grantee’s unexercised SARs or for the then
Fair Market Value of shares of Company Stock underlying the Grantee’s Stock Awards.

     12. Requirements for Issuance or Transfer of Shares

     (a) Limitations on Issuance or Transfer of Shares. No Company Stock shall be issued
or transferred in connection with any Grant hereunder unless and until all legal requirements
applicable to the issuance or transfer of such Company Stock have been complied with. Any Grant
made shall be conditioned on the Grantee’s undertaking in writing to comply with such restrictions
on his or her subsequent disposition of such shares of Company Stock, and certificates representing
such shares may be legended to reflect any such restrictions. Certificates representing shares of
Company Stock issued or transferred under the Plan will be subject to such stop-transfer orders and
other restrictions as may be required by applicable laws, regulations and interpretations,
including any requirement that a legend be placed thereon.

     (b) Lock-Up Period. If so requested by the Company or any representative of the
underwriters (the “Managing Underwriter”) in connection with any underwritten offering of
securities of the Company under the Securities Act of 1933, as amended (the “Securities Act”), a
Grantee (including any successor or assigns) shall not sell or otherwise transfer any shares or
other securities of the Company during the thirty (30) day period preceding and the one hundred
eighty (180)-day period following the effective date of a registration statement of the Company
filed under the Securities Act for such underwriting (or such shorter period as may be requested by
the Managing Underwriter and agreed to by the Company) (the “Market Standoff Period”). The Company
may impose stop-transfer instructions with respect to securities subject to the foregoing
restrictions until the end of such Market Standoff Period.

     13. Amendment and Termination of the Plan

     (a) Amendment. The Board or its delegate may amend or terminate the Plan at any time;
provided, however, that neither the Board nor its delegate shall have the authority to amend the
Plan without shareholder approval if such approval is required in order to comply with the Code or
other applicable laws, or to comply with applicable stock exchange requirements.

-14-

 

     (b) Termination of Plan. The Plan shall terminate on the day immediately preceding
the tenth (10th) anniversary of its effective date, unless the Plan is terminated
earlier by the Company or is extended by the Company with the
approval of the shareholders.

     (c) Termination and Amendment of Outstanding Grants. A termination or amendment of
the Plan that occurs after a Grant is made shall not materially impair the rights of a Grantee
unless the Grantee consents or unless the Company acts under Section 19(b). The termination of the
Plan shall not impair the power and authority of the Company with respect to an outstanding Grant.
Whether or not the Plan has terminated, an outstanding Grant may be terminated or amended under
Section 19(b) or may be amended by agreement of the Company and the Grantee consistent with the
Plan.

     (d) Governing Document. The Plan shall be the controlling document. No other
statements, representations, explanatory materials or examples, oral or written, may amend the Plan
in any manner. The Plan shall be binding upon and enforceable against the Company and its
successors and assigns.

     14. Funding of the Plan

     This Plan shall be unfunded. The Company shall not be required to establish any special or
separate fund or to make any other segregation of assets to assure the payment of any Grants under
this Plan. In no event shall interest be paid or accrued on any Grant, including unpaid
installments of Grants.

     15. Rights of Participants

     Nothing in this Plan shall entitle any Employee, Key Advisor, Non-Employee Director, or other
person to any claim or right to be granted a Grant under this Plan. Neither this Plan nor any
action taken hereunder shall be construed as giving any individual any rights to be retained by or
in the employ of the Employer or any other employment rights.

     16. No Fractional Shares

     No fractional shares of Company Stock shall be issued or delivered pursuant to the Plan or any
Grant. The Company shall determine whether cash, other awards or other property shall be issued or
paid in lieu of such fractional shares or whether such fractional shares or any rights thereto
shall be forfeited or otherwise eliminated.

     17. Headings

     Section headings are for reference only. In the event of a conflict between a title and the
content of a Section, the content of the Section shall control.

     18. Effective Date of the Plan

     The Plan shall be effective on April 11, 2006.

-15-

 

     19. Miscellaneous

     (a) Grants in Connection with Corporate Transactions and Otherwise. Nothing contained
in this Plan shall be construed to (i) limit the right of the Company to make Grants under this
Plan in connection with the acquisition, by purchase, lease, merger, consolidation or otherwise, of
the business or assets of any corporation, firm or association, including Grants to employees
thereof who become Employees, or for other proper corporate purposes, or (ii) limit the right of
the Company to grant stock options or make other awards outside of this Plan. Without limiting the
foregoing, the Company may make a Grant to an employee of another corporation who becomes an
Employee by reason of a corporate merger, consolidation, acquisition of stock or property,
reorganization or liquidation involving the Company, the parent or any of their subsidiaries in
substitution for a stock option or Stock Awards grant made by such corporation. The terms and
conditions of the substitute grants may vary from the terms and conditions required by the Plan and
from those of the substituted stock incentives. The Company shall prescribe the provisions of the
substitute grants.

     (b) Compliance with Law. The Plan, the exercise of Options and SARs, and the
obligations of the Company to issue or transfer shares of Company Stock under Grants shall be
subject to all applicable laws and to approvals by any governmental or regulatory agency as may be
required. With respect to persons subject to Section 16 of the Exchange Act it is the intent of
the Company that the Plan and all transactions under the Plan comply with all applicable provisions
of Rule 16b-3 or its successors under the Exchange Act. In addition, it is the intent of the
Company that the Plan and applicable Grants under the Plan comply with the applicable provisions of
Section 162(m) of the Code and Section 422 of the Code. To the extent that any legal requirement
of Section 16 of the Exchange Act or Section 162(m) or 422 of the Code as set forth in the Plan
ceases to be required under Section 16 of the Exchange Act or Section 162(m) or 422 of the Code,
that Plan provision shall cease to apply. The Company may revoke any Grant if it is contrary to
law or modify a Grant to bring it into compliance with any valid and mandatory government
regulation. The Company may also adopt rules regarding the withholding of taxes on payments to
Grantees. The Company may, in its sole discretion, agree to limit its authority under this
Section.

     (c) Employees Subject to Taxation Outside the United States. With respect to Grantees
who are subject to taxation in countries other than the United States, Grants may be made on such
terms and conditions as the Company deems appropriate to comply with the laws of the applicable
countries, and the Company may create such procedures, addenda and subplans and make such
modifications as may be necessary or advisable to comply with such laws.

     (d) Governing Law. The validity, construction, interpretation, and effect of the Plan
and Grant Instruments issued under the Plan shall be governed and construed by and determined in
accordance with the laws of the State of New Jersey, without giving effect to the conflict of laws
provisions thereof.

-16-exv4w1

Exhibit 4.1

MEMBER CAPITAL SECURITIES MAY NOT BE TRANSFERRED WITHOUT THE PRIOR WRITTEN CONSENT OF NATIONAL
RURAL UTILITIES COOPERATIVE FINANCE CORPORATION (“NATIONAL RURAL”) AND ONLY NATIONAL RURAL’S VOTING
MEMBERS MAY PURCHASE AND HOLD THE MEMBER CAPITAL SECURITIES. ANY PURPORTED TRANSFER OF MEMBER
CAPITAL SECURITIES WITHOUT NATIONAL RURAL’S PRIOR WRITTEN CONSENT WILL BE VOID AB INITIO.

Certificate No.:

PRINCIPAL AMOUNT:

INTEREST RATE:

MATURITY DATE:

ISSUE DATE:

INTEREST PAYMENT DATES:

REGULAR RECORD DATES:

NATIONAL RURAL UTILITIES COOPERATIVE FINANCE CORPORATION

MEMBER CAPITAL SECURITIES

     National Rural Utilities Cooperative Finance Corporation, a cooperative association duly
organized and existing under the laws of the District of Columbia (herein referred to as the
“Company”, which term includes any successor Person under the Indenture), for value received,
hereby promises to pay to                               , or registered assigns, the
principal sum of                               on the Maturity Date set forth above and to pay
interest thereon as set forth below, until the principal hereof is paid or made available for
payment.

     Interest on the member capital securities (the “Securities”) will be payable
 in
arrears on the Interest Payment Dates set forth above of each year, and at maturity, commencing on
                     , 20XX, at the rate of [        ]% per annum.

     The interest so payable, and punctually paid or duly provided for, on any Interest Payment
Date will be payable to, as provided in such Indenture, the Person in whose name this Security is
registered at the close of business on the Regular Record Dates set forth above of each year.
Interest will be paid on such principal sum from the Maturity Date or from the most recent Interest
Payment Date until the principal amount thereof becomes due and payable.

 

 

     Reference is hereby made to the further provisions of this Security set forth on the reverse
hereof, which further provisions shall for all purposes have the same effect as if forth at this
place.

     Unless the certificate of authentication hereon has been executed by the Trustee referred to
on the reverse hereof by manual signature, this Security shall not be entitled to any benefit under
the Indenture or be valid or obligatory for any purpose.

 

 

     IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed.

	 	 	 	 	 
	 	NATIONAL RURAL UTILITIES

COOPERATIVE FINANCE CORPORATION

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

	 	 	 	 	 
	ATTEST:

 	 	 
	
 	 	 
	 	 	 
	 	 	 

 

 

	 	 	 	 	 

CERTIFICATE OF AUTHENTICATION

Dated:

     This is one of the Securities of the series designated herein referred to in the
within-mentioned Indenture.

	 	 	 	 	 
	 	U.S. BANK NATIONAL ASSOCIATION

 	 
	 	By:  	 	 
	 	 	Authorized Signatory 	 
	 	 	 	 

 

 

	 	 	 	 	 

REVERSE OF SECURITY

     This Security is one of a duly authorized issue of subordinated debt securities of the Company
(the “member capital securities,” and, herein called the “Securities”), issued and to be issued in
one or more series under an Indenture, dated as of October 15, 1996, as amended (herein called the
“Indenture”, which term shall have the meaning assigned to it in such instrument), between the
Company and U.S. Bank National Association, as successor trustee (herein called the “Trustee”,
which term includes any successor trustee under the Indenture), and reference is hereby made to the
Indenture for a statement of the respective rights, limitations of rights, duties and immunities
thereunder of the Company, the Trustee and the Holders of the Securities and of the terms upon
which the Securities are, and are to be, authenticated and delivered. This Security is one of the
series designated on the face hereof, which series is limited in aggregate principal amount to an
amount not to exceed $165,000,000.

     The amount of interest payable on any Interest Payment Date shall be computed on the basis of
a 360-day year of twelve 30-day months.

     In the event that any date on which interest is payable on the Securities is not a Business
Day, then payment of the interest payable on such date will be made on the next succeeding day
which is a Business Day (and without any interest or other payment in respect of any such delay),
except that, if such Business Day is in the following month, such payment will be made on the
immediately preceding Business Day, in each case with the same force and effect as if made on such
date. A “Business Day” is any week day other than a day on which banking institutions in the
borough of Manhattan, city and state of New York are authorized by law to close or on which the
Company is closed.

     Any such interest not so punctually paid or duly provided for will forthwith cease to be
payable to the Holder on such Regular Record Date and may either be paid to the Person in whose
name this Security (or one or more Predecessor Securities) is registered at the close of business
on a Special Record Date for the payment of such Defaulted Interest to be fixed by the Trustee,
notice whereof shall be given to Holders of Securities of this series not less than 10 days prior
to such Special Record Date, or be paid at any time in any other
lawful manner,

 

 

as more
fully provided in the Indenture referred to on the reverse hereof.

     Each Security will be issued in certificated form. Payment of the principal of and any
interest on this Security payable at maturity or upon redemption will be made in immediately
available funds at the office of the paying agent in the Borough of Manhattan, the City of New
York. Payments in immediately available funds will be made only if the Security is presented to
the paying agent in time for the paying agent to make payments in immediately available funds in
accordance with normal procedures. Interest on the Security will be paid by wire transfer in
immediately available funds, but only if appropriate instructions have been received in writing by
the paying agent on or prior to the applicable regular record date for the payment of interest. If
no instructions have been received in writing by the paying agent, the funds will be paid by check
mailed to the address of the person entitled to such interest.

     The Securities of this series are subject to redemption upon not less than 30 nor more than 60
days’ notice by mail, at any time on or after the date that is five years from the Issue Date set
forth on the front of this Security, as a whole or in part, at the election of the Company, at a
Redemption Price equal to 100% of the principal amount to be redeemed, together in the case of any
such redemption with accrued interest to, but not including, the Redemption Date, but interest
installments whose Stated Maturity is on or prior to such Redemption Date will be payable to the
Holder of such Security, or one or more Predecessor Securities, of record at the close of business
on the related Regular Record Date referred to on the face hereof, all as provided in the
Indenture.

     In the event of redemption of this Security in part only, a new Security or Securities of this
series and of like tenor for the unredeemed portion hereof will be issued in the name of the Holder
hereof upon the cancellation hereof.

     The indebtedness evidenced by this Security is unsecured and subordinated and subject in right
of payment to the prior payment in full of all Senior Indebtedness, which shall include all
subordinated indebtedness of the Company that may be held by or transferred to non-members of the
Company, and this Security is issued subject to the provisions of the Indenture with respect
thereto. The Securities of this series will rank pari passu to the Company’s member subordinated
certificates and unretired patronage capital. Each Holder of this Security, by accepting the same,
(a) agrees to and shall be bound by such provisions, (b) authorizes and

 

 

directs the Trustee on his behalf to take such action as may be necessary or appropriate to
acknowledge or effectuate the subordination so provided and (c) appoints the Trustee his
attorney-in-fact for any and all such purposes. Each Holder hereof, by his acceptance hereof,
hereby waives all notice of the acceptance of the subordination provisions contained herein and in
the Indenture by each holder of such Senior Indebtedness, whether now outstanding or hereafter
incurred, and waives reliance by each such Holder upon said provisions.

     The Indenture contains provisions for defeasance at any time of the entire indebtedness of
this Security upon compliance with certain conditions set forth in the Indenture.

     If an Event of Default with respect to Securities of this series shall occur and be
continuing, the principal of the Securities of this series may be declared due and payable in the
manner and with the effect provided in the Indenture.

     In addition to the events of default set forth in the Indenture, the following will constitute
an Event of Default under the Indenture with respect to the Securities: the Company shall pay any
dividend or interest on, or principal of, or redeem, purchase, acquire, retire or make a
liquidation payment with respect to, any Members’ Subordinated Certificates, Members’ Equity or
patronage capital, if such payment is made during an Extension Period, and either (i) such
Extension Period has not expired or been terminated or (ii) the Company has not made all payments
due on the Securities as a result of such expiration or termination.

     No payment will be made in respect of the Securities if, at the time of such payment or
immediately after giving effect thereto, (i) there exists a default by the Company in the payment
of principal or mandatory prepayments or premium, if any, of sinking funds or interest on any
senior or subordinated indebtedness (as defined in the instrument under which the same is
outstanding) of the Company, or (ii) there shall have occurred an event of default (other than a
default in the payment of principal, premium, if any, mandatory prepayments, sinking funds or
interest) with respect to any senior or subordinated indebtedness as defined in the instrument
under which the same is outstanding permitting the holders thereof (or of the indebtedness secured
thereby) to accelerate the maturity thereof (or of the indebtedness secured thereby), and such
event of default shall not have been cured or waived or shall not have ceased to exist.

     The Indenture permits, with certain exceptions as therein provided, the amendment thereof and
the modification of the rights and obligations of the Company and the

 

 

rights of the Holders of the Securities of each series to be affected under the Indenture at
any time by the Company and the Trustee with the consent of the Holders of not less than a majority
in aggregate principal amount of the Securities at the time Outstanding of each series to be
affected. The Indenture also contains provisions permitting the Holders of not less than a
majority in principal amount of the Securities of each series at the time Outstanding, on behalf of
the Holders of all Securities of such series, to waive compliance by the Company with certain
provisions of the Indenture and certain past defaults under the Indenture and their consequences.
Any such consent or waiver by the Holder of this Security shall be conclusive and binding upon such
Holder and upon all future Holders of this Security and of any Security issued upon the
registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation
of such consent or waiver is made upon this Security.

     As provided in and subject to the provisions of the Indenture, the Holder of this Security
shall not have the right to institute any proceeding with respect to the Indenture or for the
appointment of a receiver or trustee or for any other remedy thereunder, unless such Holder shall
have previously given the Trustee written notice of a continuing Event of Default with respect to
the Securities of this series, the Holders of not less than 33 1/3% in aggregate principal amount
of the Securities of this series at the time Outstanding shall have made written request to the
Trustee to institute proceedings in respect of such Event of Default as Trustee and offered the
Trustee reasonable indemnity, and the Trustee shall not have received from the Holders of a
majority in aggregate principal amount of Securities of this series at the time Outstanding a
direction inconsistent with such request, and shall have failed to institute any such proceeding,
for 60 days after receipt of such notice, request and offer of indemnity. The foregoing shall not
apply to any suit instituted by the Holder of this Security for the enforcement of any payment of
principal hereof or interest hereon on or after the respective due dates expressed herein.

     No reference herein to the Indenture and no provision of this Security or of the Indenture
shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay
the principal of and interest on this Security at the times, place and rate, and in the coin or
currency, herein prescribed.

     The Company may at its option at any time and from time to time during the term of the
Securities of this series defer the interest payment period for a period not exceeding 10
consecutive semi-annual interest payments (or an equivalent period of
quarterly or other interest payment periods) (a “Deferral Period”), and at the end of such Deferral

 

 

Period, the Company shall pay all interest then accrued and unpaid (together with interest
thereon at the same rate as specified for the Securities of this series to the extent permitted by
applicable law) through the last day of such Deferral Period, provided that if any principal amount
of this Security is paid on such day, then not including interest for such day with respect to such
principal amount; provided, that during such Deferral Period the Company may not declare or pay any
dividend or interest on, or principal of, or redeem, purchase, acquire or make a liquidation
payment with respect to, any of its Members’ Subordinated Certificates, Members’ Equity or
patronage capital. Prior to the termination of any such Deferral Period, the Company may further
defer the payment of interest, provided that such Deferral Period, together with all such previous
and further deferrals thereof, may not exceed 10 consecutive semi-annual interest payment periods
(or an equivalent period of
quarterly or other interest payment periods) or extend beyond the Stated Maturity of the Securities of this series. Upon the termination of any
such Deferral Period and the payment of all amounts then due, the Company may elect a new Deferral
Period, subject to the above conditions. No interest during a Deferral Period, except at the end
thereof, shall be due and payable. The Company shall give the Holder of this Security notice of
its intent to defer payment of interest in writing at least ten business days before the earlier of
(i) the next interest payment due date and (ii) the date CFC is required to give notice to holders
of the Securities of the record or payment date for such interest payment.

     The Securities of this series are issuable only in registered form without coupons and in
minimum denominations of $25,000 and integral multiples of $5,000 in excess thereof. As provided
in the Indenture and subject to certain limitations therein set forth, Securities of this series
are exchangeable for a like aggregate principal amount of Securities of this series and of like
tenor and of authorized denominations, as requested by the Holder surrendering the same.

     No service charge shall be made for any such registration of transfer or exchange, but the
Company may require payment of a sum sufficient to cover any tax or other governmental charge
payable in connection therewith.

     The Company, the Trustee and any agent of the Company or the Trustee may treat the Person in
whose name this Security is registered as the absolute owner hereof for all purposes, whether or
not this Security be overdue, and neither the Company, the Trustee nor any such agent shall be
affected by notice to the contrary.

     The Securities may not be transferred without the Company’s prior written consent and only the
Company’s voting members may purchase and hold the securities. Any

 

 

purported transfer of the Securities without the Company’s prior written consent will be void
ab initio.

     All terms used in this Security which are defined in the Indenture shall have the meanings
assigned to them in the Indenture.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00149-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00149-of-00352.parquet"}]]